r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

EI

Edward J. Dulac III

Insider · EVP, Chief Financial Officer · NTLA

Edward J. Dulac III files insider transactions with the SEC as an evp, chief financial officer of Intellia Therapeutics (NTLA). We hold 3 disclosed purchases and sales filed since 19 August 2020, 2 of them in the last 90 days.

  • Files forNTLA
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure24 July 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 July 2024 — 22 July 2026EVP, Chief Financial Officer · Intellia Therapeutics (NTLA)13 Form 4 lines · source: SEC Form 4
  • Filed 17 August 2020 — 4 March 2024Chief Financial Officer · Fate Therapeutics (FATE)30 Form 4 lines · source: SEC Form 4

Everything they disclosed

43 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.